Henry Schein's (NASDAQ:HSIC) Q3 2026 earnings results: revenue in line with expectations

What happened

Henry Schein reported Q3 2026 revenue of $3.47 billion, up 4% year on year and in line with analysts' estimates. Adjusted profit was $1.56 per share, a 14.9% beat, and the company raised its full-year adjusted profit guidance to $5.53 at the midpoint.

Confirmed

Global impact / market context

Higher profit per share despite only in-line sales suggests Henry Schein kept costs in check and sold more profitable products. The raised guidance signals management expects this momentum to continue, which matters because future profit guidance often shapes how investors value the stock.

Analyst inference

Revenue matched expectations while profit beat them, a pattern that can support the share price because earnings power improved without extra sales. Free cash flow margin of 3.3% and a 5.6% operating margin, both flat year on year, show the beat came from profit per sale rather than a sudden business shift.

Analyst inference

What to watch

1. Watch whether U.S. dental merchandise sales growth of 8.6% holds up next quarter, since management credited volume in a stable market for that gain. Confirmed
2. Track whether Henry Schein delivers the raised full-year adjusted profit guidance of $5.53 at the midpoint, which depends on keeping costs and profit per sale steady. Proposed
3. Monitor organic revenue growth of 3.1%, which missed expectations; if it stays weak, future sales growth may rely on price increases rather than more products sold. Analyst inference

Evidence

• stockstory.org